New hope for Tough-to-Treat Heart-Lung condition
Disease control
Recruiting now
This study is testing whether adding a medication called sotatercept to standard treatments helps adults with pulmonary arterial hypertension (PAH) caused by unrepaired congenital heart defects, including Eisenmenger syndrome. About 36 adults in Japan whose PAH hasn't improved en…
Phase: PHASE4 • Sponsor: Kazuya Hosokawa • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC